CVE-2024-56472 Details
Description
IBM Aspera Shares 1.9.0 through 1.10.0 PL6 is vulnerable to stored cross-site scripting. This vulnerability allows authenticated users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
A stored cross-site scripting vulnerability has been identified in IBM Aspera Shares versions 1.9.0 through 1.10.0 PL6. This issue allows authenticated users to inject arbitrary JavaScript into the Web UI, potentially altering functionality and leading to credential disclosure within a trusted session.
Users are advised to upgrade to IBM Aspera Shares version 1.10.0 PL7. Instructions for downloading this version are available on the IBM Support Fix Central website.
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Feb 6, 2025References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://www.ibm.com/support/pages/node/7182490 | [email protected] | Vendor Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-79 | Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| ibm aspera shares | >= 1.9.0, < 1.10.0 1.10.0 - 1.10.0 patch_level1 1.10.0 patch_level2 1.10.0 patch_level3 1.10.0 patch_level4 1.10.0 patch_level5 1.10.0 patch_level6 |
CPE
Remediation
| |
Change History
4 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Mar 7, 2025 | Initial Analysis | [email protected] |
| Feb 5, 2025 | New CVE Received | [email protected] |